1 / 2

Mortality for Autologous HSCT for Autoimmune Diseases at other institutions

Mortality for Autologous HSCT for Autoimmune Diseases at other institutions. SLE European data: 12% TRM, 23% OM MS European data: 6% TRM, 8% OM MS Seattle data: 4% TRM, 8% OM Scleroderma European data: 9% TRM, 23% OM Scleroderma Seattle data: 16% TRM, 21% OM

apollo
Download Presentation

Mortality for Autologous HSCT for Autoimmune Diseases at other institutions

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Mortality for Autologous HSCT for Autoimmune Diseases at other institutions • SLE European data: 12% TRM, 23% OM • MS European data: 6%TRM, 8% OM • MS Seattle data: 4%TRM, 8% OM • Scleroderma European data: 9%TRM, 23% OM • Scleroderma Seattle data: 16%TRM, 21% OM • RA European data: 1.3%TRM, OM unknown

  2. Mortality for Autologous HSCT Autoimmune Diseaseat Northwestern University Total 123/137 alive: 1.5% TRM (2), 10.2% OM (14) • SLE: 44/53 alive: 1.9% TRM (1), 17 % OM (9) • MS (old): 18/21 alive: 0% TRM (0), 14% OM (3) • MS (new): 23/23 alive: 0% TRM, 0% OM • Scleroderma: 10/10 alive: 0% TRM, 0% OM • Crohn’s: 15/16 alive: 0% TRM, 6% OM (1) • RA: 4/4 alive: 0% TRM, 0% OM • Vasculitis: 4/4 alive: 0% TRM, 0% OM • RP/pemphigus/ARRON/CIDP: 4/4 alive: 0% TRM, 0% OM • MG: 1/2 alive: 50% TRM (1), 50% OM (1)

More Related